Literature DB >> 24413642

GLUT1 deficiency syndrome into adulthood: a follow-up study.

W G Leen1, M Taher, M M Verbeek, E J Kamsteeg, B P van de Warrenburg, M A Willemsen.   

Abstract

GLUT1 deficiency syndrome (GLUT1DS) is a treatable neurometabolic disorder in which glucose transport into the brain is disturbed. Besides the classic phenotype of intellectual disability, epilepsy, and movement disorders, other phenotypes are increasingly recognized. These include, for example, idiopathic generalized epilepsy and paroxysmal exercise-induced dyskinesia. Since the disorder has only been recognized for two decades and is mostly diagnosed in children, little is known about the disease course. Our purpose was to investigate the disease course of GLUT1DS patients with the classic, complex phenotype from infancy into adulthood. We performed a systematic literature review as well as a cohort study, including GLUT1DS patients aged 18 years and older. The literature search yielded a total of 91 adult GLUT1DS patients, of which 33 patients (one-third) had a complex phenotype. The cohort study included seven GLUT1DS patients with a complex phenotype who were prospectively followed up in our clinic from childhood into adulthood. Our results show that epilepsy is a prominent feature during childhood in classic GLUT1DS patients. During adolescence, however, epilepsy diminishes or even disappears, but new paroxysmal movement disorders, especially paroxysmal exercise-induced dyskinesia, either appear or worsen if already present in childhood. Intellectual disability was not systematically assessed, but cognitive functions appeared to be stabile throughout life. Like children, adolescents may benefit from a ketogenic diet or variants thereof.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24413642     DOI: 10.1007/s00415-014-7240-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  26 in total

Review 1.  The cerebellum in dystonia - help or hindrance?

Authors:  A Sadnicka; B S Hoffland; K P Bhatia; B P van de Warrenburg; M J Edwards
Journal:  Clin Neurophysiol       Date:  2011-11-09       Impact factor: 3.708

2.  Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency.

Authors:  S A Mullen; A Suls; P De Jonghe; S F Berkovic; I E Scheffer
Journal:  Neurology       Date:  2010-06-23       Impact factor: 9.910

Review 3.  A critical period of brain development: studies of cerebral glucose utilization with PET.

Authors:  H T Chugani
Journal:  Prev Med       Date:  1998 Mar-Apr       Impact factor: 4.018

4.  Exercise-induced changes in local cerebral glucose utilization in the rat.

Authors:  J Vissing; M Andersen; N H Diemer
Journal:  J Cereb Blood Flow Metab       Date:  1996-07       Impact factor: 6.200

5.  Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects.

Authors:  Dong Wang; Juan M Pascual; Hong Yang; Kristin Engelstad; Sarah Jhung; Ruo Peng Sun; Darryl C De Vivo
Journal:  Ann Neurol       Date:  2005-01       Impact factor: 10.422

Review 6.  Phenotypic spectrum of glucose transporter type 1 deficiency syndrome (Glut1 DS).

Authors:  Toni S Pearson; Cigdem Akman; Veronica J Hinton; Kristin Engelstad; Darryl C De Vivo
Journal:  Curr Neurol Neurosci Rep       Date:  2013-04       Impact factor: 5.081

Review 7.  Glucose transporter deficiency syndrome (GLUT1DS) and the ketogenic diet.

Authors:  Jörg Klepper
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

8.  Glucose transporter 1 deficiency in the idiopathic generalized epilepsies.

Authors:  Todor Arsov; Saul A Mullen; Sue Rogers; A Marie Phillips; Kate M Lawrence; John A Damiano; Hadassa Goldberg-Stern; Zaid Afawi; Sara Kivity; Chantal Trager; Steven Petrou; Samuel F Berkovic; Ingrid E Scheffer
Journal:  Ann Neurol       Date:  2012-11       Impact factor: 10.422

9.  A mouse model for Glut-1 haploinsufficiency.

Authors:  Dong Wang; Juan M Pascual; Hong Yang; Kristin Engelstad; Xia Mao; Jianfeng Cheng; Jong Yoo; Jeffrey L Noebels; Darryl C De Vivo
Journal:  Hum Mol Genet       Date:  2006-02-23       Impact factor: 6.150

10.  Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1.

Authors:  Arvid Suls; Peter Dedeken; Karolien Goffin; Hilde Van Esch; Patrick Dupont; David Cassiman; Judith Kempfle; Thomas V Wuttke; Yvonne Weber; Holger Lerche; Zaid Afawi; Wim Vandenberghe; Amos D Korczyn; Samuel F Berkovic; Dana Ekstein; Sara Kivity; Philippe Ryvlin; Lieve R F Claes; Liesbet Deprez; Snezana Maljevic; Alberto Vargas; Tine Van Dyck; Dirk Goossens; Jurgen Del-Favero; Koen Van Laere; Peter De Jonghe; Wim Van Paesschen
Journal:  Brain       Date:  2008-06-24       Impact factor: 13.501

View more
  27 in total

Review 1.  Glucose Transporters at the Blood-Brain Barrier: Function, Regulation and Gateways for Drug Delivery.

Authors:  Simon G Patching
Journal:  Mol Neurobiol       Date:  2016-01-22       Impact factor: 5.590

2.  A Case of Progressive Chorea Resulting From GLUT1 Deficiency.

Authors:  Ichraf Kraoua; Hanene Benrhouma; Sandrine Vuillaumier-Barrot; Hedia Klaa; Ilhem Ben Youssef-Turki
Journal:  Mov Disord Clin Pract       Date:  2015-08-18

3.  Crystal structure of the human glucose transporter GLUT1.

Authors:  Dong Deng; Chao Xu; Pengcheng Sun; Jianping Wu; Chuangye Yan; Mingxu Hu; Nieng Yan
Journal:  Nature       Date:  2014-05-18       Impact factor: 49.962

4.  Early-onset genetic epilepsies reaching adult clinics.

Authors:  David Lewis-Smith; Colin A Ellis; Ingo Helbig; Rhys H Thomas
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

5.  GLUT1 and COVID-19 deficiency syndrome.

Authors:  Francisco Arrieta Blanco; Amaya Bélanger Quintana; Nuria Bengoa Rojano; Sinziana Stanescu; Mercedes Martinez Pardo
Journal:  Endocrinol Diabetes Nutr (Engl Ed)       Date:  2020-09-01       Impact factor: 1.417

Review 6.  Recent advances in epilepsy.

Authors:  Mark Manford
Journal:  J Neurol       Date:  2017-01-24       Impact factor: 4.849

Review 7.  Different Prognostic Patterns in Epilepsies and Considerations About the Denotations of Atypical Patterns.

Authors:  Arife Çimen Atalar; Betül Baykan
Journal:  Noro Psikiyatr Ars       Date:  2022-01-31       Impact factor: 1.339

8.  Cortical Dysplasia in Rats Provokes Neurovascular Alterations, GLUT1 Dysfunction, and Metabolic Disturbances That Are Sustained Post-Seizure Induction.

Authors:  Chaitali Ghosh; Rosemary Myers; Christina O'Connor; Sherice Williams; Xuefeng Liu; Mohammed Hossain; Michael Nemeth; Imad M Najm
Journal:  Mol Neurobiol       Date:  2022-01-27       Impact factor: 5.682

9.  Severe familial paroxysmal exercise-induced dyskinesia.

Authors:  Pawel Tacik; Sebastian Loens; Christoph Schrader; Sabine Gayde-Stephan; Saskia Biskup; Dirk Dressler
Journal:  J Neurol       Date:  2014-08-07       Impact factor: 4.849

Review 10.  Glucose Transporter Type I Deficiency (G1D) at 25 (1990-2015): Presumptions, Facts, and the Lives of Persons With This Rare Disease.

Authors:  Juan M Pascual; Gabriel M Ronen
Journal:  Pediatr Neurol       Date:  2015-08-10       Impact factor: 3.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.